OncLive | Gradishar Provides Insight into New Breast Cancer Treatments OncLive Trials and analysis continue to hone our understanding of how and when mTOR inhibitors such as everolimus (Afinitor) counter resistance to aromatase inhibitors in metastatic cancer. New trials, meanwhile, are beginning to explore whether the drug ... |
